Cargando…

Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?

Detalles Bibliográficos
Autores principales:	Buse, John B., D’Alessio, David A., Riddle, Matthew C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2018
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054497/ https://www.ncbi.nlm.nih.gov/pubmed/29941499 http://dx.doi.org/10.2337/dci18-0025

Ejemplares similares

Further RISE’ing to the Challenge of Type 2 Diabetes in Youth
por: Klein, Klara R., et al.
Publicado: (2021)

Vaccines for Gonorrhea: Can We Rise to the Challenge?
por: Zhu, Weiyan, et al.
Publicado: (2011)

Similarities and differences in the natural history of youth‐onset type 2 diabetes between the West and Asia
por: Yen, Fu‐Shun, et al.
Publicado: (2022)

How can we Challenge the Four-minute Rule?
por: Naruse, Katsuhiko
Publicado: (2016)

The new Veterinary Medicines Regulation: rising to the challenge
por: More, Simon J., et al.
Publicado: (2022)

Combatting Substandard and Counterfeit Medicines in the Nigerian Drug Market: How Industrial Pharmacists Can Rise Up to the Challenge
por: Okereke, Melody, et al.
Publicado: (2021)

Antimicrobial resistance and inappropriate use of antimicrobials: Can we rise to the challenge?
por: Chandy, Sujith J.
Publicado: (2015)

Personalized cancer screening: helping primary care rise to the challenge
por: Selby, Kevin, et al.
Publicado: (2018)

Commentary: Pleurography: We can, but should we?
por: Benz, Cecilia, et al.
Publicado: (2021)

Taking Aim at Islet Hormones With GLP-1: Is Insulin or Glucagon the Better Target?
por: D'Alessio, David A.
Publicado: (2010)

“Stewards of the future: accompanying the rising tide of young voices by setting youth-inclusive research agendas in sustainability research”
por: Barraclough, Alicia Donnellan, et al.
Publicado: (2021)

A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and Opportunities
por: Currie, Brooke M., et al.
Publicado: (2021)

Glucagon‐like peptide‐1 therapy for youth with type 2 diabetes
por: Cho, Young Min
Publicado: (2022)

An Innate Disposition for a Healthier Gut: GLP-1R Signaling in Intestinal Epithelial Lymphocytes
por: Rosario, Wilfredo, et al.
Publicado: (2015)

BMI Guidelines for Bariatric Surgery in Diabetes: How Low Can We Go?
por: Ryan, Donna H.
Publicado: (2012)

Commentary: Because we can
por: Hanna, Waël C.
Publicado: (2020)

The Coronavirus Disease 2019 Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 Diabetes
por: Magge, Sheela N., et al.
Publicado: (2022)

How can we realise the potentially large public health benefit of screening for type 2 diabetes mellitus in south Asians?
por: Stronks, K., et al.
Publicado: (2011)

Losing a Grip on the Notion of β-Cell Specificity for Immune Responses in Type 1 Diabetes: Can We Handle the Truth?
por: Atkinson, Mark A.
Publicado: (2014)

Screening for type 1 diabetes: are we nearly there yet?
por: Narendran, Parth
Publicado: (2018)

Can We Become Victims of Our Own Success?
por: Buse, John B.
Publicado: (2009)

Crisis in Care: Limited Treatment Options for Type 2 Diabetes in Adolescents and Youth
por: Tamborlane, William V., et al.
Publicado: (2013)

Commentary: Artificial intelligence for everything: Can we trust it?
por: Akkara, John Davis, et al.
Publicado: (2020)

Silence sexual and reproductive health discussions and we fuel the rise of HIV/AIDS in sub-Saharan Africa
por: Wojcicki, Janet M.
Publicado: (2017)

Going With the Flow: Adaptation of β-Cell Function to Glucose Fluxes After Bariatric Surgery
por: Salehi, Marzieh, et al.
Publicado: (2013)

Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?
por: Brady, O’Dane, et al.
Publicado: (2013)

Gastrointestinal dysfunction in the critically ill: can we measure it?
por: Khadaroo, Rachel G, et al.
Publicado: (2008)

The Far Right Challenge: Comment on "The Rise of Post-truth Populism in Pluralist Liberal Democracies: Challenges for Health Policy"
por: Halikiopoulou, Daphne
Publicado: (2017)

Rise and rise of anesthesiologists under the shadow of COVID-19
por: Gondode, Prakash Gyandev, et al.
Publicado: (2021)

Glargine and Cancer: Can We Now Suggest Closure?
por: Owens, David R.
Publicado: (2012)

Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities
por: Nadeau, Kristen J., et al.
Publicado: (2016)

How can we improve the interpretation of systematic reviews?
por: Tricco, Andrea C, et al.
Publicado: (2011)

How do we best relax control measures as vaccine coverage for SARS-CoV-2 rises?
por: Foy, Brody H, et al.
Publicado: (2021)

Diabetes Care: “Lagniappe” and “Seeing Is Believing”!
por: Cefalu, William T., et al.
Publicado: (2016)

Should we, can we, halt the rise in prescribing for pain and distress?
por: Byng, Richard
Publicado: (2020)

Multidisciplinary Management of Diabetic Foot Ulcers in Primary Cares in Quebec: Can We Do Better?
por: Brousseau-Foley, Magali, et al.
Publicado: (2020)

Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
por: Nedeljković, Milica, et al.
Publicado: (2019)

Salamanders and fish can regenerate lost structures - why can't we?
por: Simon, Hans-Georg
Publicado: (2012)

Long COVID: Does It Exist? What Is It? We Can We Do For Sufferers?
por: Hoffer, Edward P.
Publicado: (2021)

Commentary: Just because we can, doesn't always mean we should
por: Nellis, Joseph R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ja9cqrum5i4vgmv9ullflff94q